图片来源:视觉中国蓝鲸新闻1月5日讯近日,根据国家药监督官微信息显示,2025年我国已批准上市的创新药达76个,大幅超过2024年全年48个,创历史新高。此外,2025年我国创新药对外授权交易总金额超过1300亿美元,授权交易数量超过150笔,远超2024年全年519亿美元和94笔,同样创历史新高。2026年,生物医药首例BD交易发生在AI制药领域,根据港股上市公司英硅智能公告显示,其与施维雅达成...
Source Link图片来源:视觉中国蓝鲸新闻1月5日讯近日,根据国家药监督官微信息显示,2025年我国已批准上市的创新药达76个,大幅超过2024年全年48个,创历史新高。此外,2025年我国创新药对外授权交易总金额超过1300亿美元,授权交易数量超过150笔,远超2024年全年519亿美元和94笔,同样创历史新高。2026年,生物医药首例BD交易发生在AI制药领域,根据港股上市公司英硅智能公告显示,其与施维雅达成...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.